Wide Ranks

GLTO

Galecto, Inc.

5.51

Top Statistics
Market Cap 7 M Forward PE -0.3437 Revenue Growth 0.00 %
Current Ratio 8.68 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.6160 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 19 M Total Cash Per Share 14.94 Total Debt 32000
Total Debt To Equity 0.1530 Current Ratio 8.68 Book Value Per Share 16.70
All Measures
Short Ratio 57.00 % Message Board Id finmb_154090027 Shares Short Prior Month 9376
Return On Equity -0.7261 City Copenhagen Uuid 02979a5f-1464-39f8-9850-05e5507f8b48
Previous Close 5.75 First Trade Date Epoch Utc 1 B Book Value 16.70
Beta 1.25 Total Debt 32000 Volume 11992
Price To Book 0.3300 Last Split Date 1 B Fifty Two Week Low 5.51
Total Cash Per Share 14.94 Shares Short Previous Month Date 1 B Target Median Price 10.00
Max Age 86400 Sand P52 Week Change 0.3133 Target Mean Price 10.00
Net Income To Common -21173000 Short Percent Of Float 0.0074 Implied Shares Outstanding 1 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 16450
Average Volume10days 16450 Total Cash 19 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0346 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 5.75 Target Low Price 10.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 8.04 Open 5.65
Free Cashflow -16521125 Dividend Yield 0.00 % Return On Assets -0.3429
Time Zone Short Name EST Trailing Eps -19.11 Day Low 5.51
Address1 Ole Maaloes Vej 3 Shares Outstanding 1 M Price Hint 2
Target High Price 10.00 Website https://galecto.com 52 Week Change -0.6502
Average Volume 39721 Forward Eps -18.89 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 855.50 % Last Split Factor 1:25
Regular Market Day High 5.98 Is_sp_500 False Profit Margins 0.00 %
Debt To Equity 0.1530 Fifty Two Week High 23.50 Day High 5.98
Shares Short 9470 Regular Market Open 5.65 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0072
Operating Cashflow -25161000 Currency USD Time Zone Full Name America/New_York
Market Cap 7 M Is_nasdaq_100 False Zip 2200
Quote Type EQUITY Industry Biotechnology Long Name Galecto, Inc.
Regular Market Day Low 5.51 Held Percent Institutions 0.1203 Current Price 5.51
Address2 Copenhagen N Enterprise To Ebitda 0.6160 Financial Currency USD
Current Ratio 8.68 Industry Disp Biotechnology Number Of Analyst Opinions 1
Country Denmark Float Shares 1 M Two Hundred Day Average 13.61
Enterprise Value -12389391 Forward PE -0.3437 Regular Market Volume 11992
Ebitda -20102000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases.

The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis.

It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis.

Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.